SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " matt " 3,939 found 🔀 AI-powered Shuffle
This Week’s Small Business Tech News: Apple Significantly Raises Their Prices
AI is reshaping small business IT, customer service and marketing. Learn why Microsoft agents, Apple price hikes and AI influencers matter to your business.
Venezuela's quakes proved Android's earthquake alerts matter. What about iPhone?
The alert leans on a sensor you already carry, but Apple takes a different path.
AI isn't killing real tech jobs. It's hitting here instead.
AI isn't killing tech jobs, says Cloudflare CEO Matthew Prince. It's changing which roles companies value most.
Inside the room where the smart home industry is still betting on Matter
It still Matters.
California health insurance tax hike: Will your premiums increase?
A balance act: To help fund the safety net, lawmakers have voted through a health tax extension that could increase premium costs for Californians with private insurance.
No debut, but loud cheers: Belfast crowd shows love for Vaibhav Sooryavanshi
Teenage sensation Vaibhav Sooryavanshi's India debut is still pending, but the focus shifted to Ireland's historic 34-run victory in the first T20I. Despite the loss, Shreyas Iyer vowed a strong comeback. Ireland's debutants impressed, with Jai Moondra and Matt Hollard making immediate impacts, while Abhishek Sharma's quickfire fifty wasn't enough for India.
Caitlin Clark Fans Staging Boycott For Saturday's Fever Game
This Saturday's showdown between the Indiana Fever and Los Angeles Sparks has unfortunately lost some of its appeal due to Caitlin Clark's latest injury. Clark suffered a back injury during Wednesday's loss to the Phoenix Mercury. To make matters worse, she was on the receiving end of a cheap shot ...
Maryland health insurers want to raise premiums an average 13.7% for individual plans in 2027
Maryland health insurers want to raise premiums an average 13.7% for individual ACA plans in 2027
Business Matters - Sit Down with David Jaindl and Rich Lerner
Join host Tony Iannelli for a compelling conversation with David Jaindl, one of the Lehigh Valley’s leading land development professionals, and Rich Lerner of GOLF Channel. Together, they discuss the
How this A-lister ended up in 'Supergirl'
Yes, that 'Supergirl' cameo is who you think it is. Director Craig Gillespie and star Milly Alcock talk about how it came together.
Science Can Fully Explain Consciousness? By 326 Theories…
It’s supposed to be a given that machines or brain organoids might be conscious despite not knowing what that is or how it works — but preborn children can’t be…
We cut MBA prices because America needs more professionals, not fewer
America is running short on educated workers at the exact moment when they matter the most.
Small Business Central to American Prosperity Celebration
House Small Business Committee celebrates small businesses as key to American prosperity ahead of nation's 250th anniversary. Learn why Main Street matters.
Michael T. Cooney and Matthew Quinlan
Calamos Wealth Management announces the addition of two seasoned wealth management professionals. Michael T. Cooney joins the firm as a SVP, Senior Wealth Advisor, and Matthew Quinlan joins as a Wealth Advisor.
Why where you live matters for heart health — even in childhood - Baylor College of Medicine Blog Network
Evidence links environmental exposures to early cardiovascular risk, disproportionately impacting marginalized communities like AI/AN youth.
Why Pollinators Matter for Human Health | Johns Hopkins Bloomberg School of Public Health
New research shows that wild insect pollinators play a critical role in nutrition and livelihoods.
The nation’s cartoonists on the week in politics
Every week political cartoonists throughout the country and across the political spectrum apply their ink-stained skills to capture the foibles, memes, hypocrisies and other head-slapping events in the world of politics. The fruits of these labors are hundreds of cartoons that entertain and enrage readers of all political stripes. Here's an offering of the best of this week's crop, picked fresh off the Toonosphere. Edited by Matt Wuerker.
Healthy Employees Are Good. Healthy Leaders Matter More
Healthy, sharp employees are essential to a strong organization. But sequencing matters. High-performing organizations start with leaders.
California unions, hospitals strike deal — but billionaire tax heads to ballot
Two healthcare ballot measures are gone. One very contentious wealth tax isn't.
Billionaire tax, affordable housing: See the measures on California's November ballot
California voters will decide on 14 statewide policy proposals come November, from the controversial billionaire tax to an $11 billion affordable housing bond.
Matt Rhule hosts youth football camp in Omaha through FlexWork Sports
Matt Rhule and four Nebraska football players made the trek to Omaha Thursday.
Larry David and Barack Obama's American history show is deeply cringe
For Larry David and Barack Obama, history is a laughing matter. And they've got the sketch comedy show to prove it.
HOMETOWN ENTERTAINMENT: A pageant finale, concerts, comedy show and New River Day
CONCERTS THIS WEEKEND: Niko Moon plays Friday in Danville and Kathy Mattea performs Sunday in Rocky Mount
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Ormond Beach businesses push drivers to slow down on Granada Boulevard
Downtown Ormond Beach businesses are taking matters into their own hands after drivers continue to ignore a reduced speed limit on Granada Boulevard — nearly a year after the change took effect.
Merck KGaA bolsters life sciences business with $11.3B Bio-Techne buy
The deal comes a matter of weeks after Kai Beckmann was promoted to CEO at Merck and signalled his intent to broaden the company's scope for M&A.
Business Briefs: June 26, 2026
Art Deviation Gallery moves GREENFIELD — Art Deviation Gallery & Store has moved from 365 Main St. to inside Whitney Hill Antiques, one-third of a mile away. Collaborators JJ White and Lee Matthew started selling items out of the 50-square-foot space they rent on Feb. 1 and closed the former location later that month. “A […]
How Elifin is reshaping the commercial real estate playbook
Elifin is leveraging a decade's worth of proprietary commercial real estate data as well as artificial intelligence to reshape how properties are marketed, analyzed and sold. The Baton Rouge-based … Already an INSIDER? Sign in. Already an INSIDER? Sign in
LA's political coalitions have been shifting. Nithya Raman will shuffle them even more
As Mayor Karen Bass and challenger Nithya Raman look to attract new supporters, a fault line between older and newer Angelenos could emerge.
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
Memphis People in Business for June 25, 2026
A look at promotions, hirings, movers and newsmakers in the Memphis area business scene
Kyle Schwarber Injury Update: Expected Return to Phillies Lineup Thursday
Philadelphia Phillies manager Don Mattingly gave an update on slugger Kyle Schwarber's injury status.
20 everyday habits that affect your heart health
Cardiovascular disease is the world's leading cause of death — and most of its risk factors are behavioral, not genetic. These are the daily habits that matter most
Health insurers propose high rate hikes for 2027 Minnesota plans
To find out why and how much it'll burden customers, policy analyst Matt McGough with KFF Health News joined Morning Edition Wednesday.
What Has Andy Burnham, Britain's Likely Next Prime Minister, Said About Trump?
If Burnham’s planned leadership bid remains unchallenged, he could replace Starmer in a matter of weeks and it will likely fall on him to heal the rift between Washington and Westminster.
Scientists discover ancient brain cells that help block distractions
Scientists have discovered a tiny group of neurons in an ancient brain region that acts like a built-in focus filter, helping the brain ignore distractions and zero in on what matters most. When researchers temporarily switched off these neurons in mice, the animals became unusually distractible—similar to what is seen in ADHD—but regained normal focus as soon as the neurons were reactivated.
The US in Brief: A big night for Zohran Mamdani
Our daily political update, featuring the stories that matter
MumFest unveils entertainment schedule for community stage
NEW BERN, Craven County — Performers will take the Howard Matthews Memorial Stage during MumFest 2026.The stage will feature performances every hour throughout
Daniel Perez appoints Matt Gaetz to Triumph Gulf Coast board
'I am returning to public service!'
'Hacks' star admits she stormed out of Emmys after losing to costar: 'Biggest sore loser'
'Hacks' star Robby Hoffman admitted she stormed out of the Emmys after losing to costar Julianne Nicholson: 'I was the biggest sore loser,' Hoffman told 'Drag Race' icon Trixie Mattel on her podcast.
"It's like lightning in a bottle" - Star Wars Galactic Racer devs spill the beans on why it's so hard to make a game as good as Burnout Paradise
Matt Webster and Kieran Crimmins recollect the creation of a racing classic, and how they're trying to strike gold twice.
I'm a billionaire founder and father of 5. I parent them differently.
Zynga founder Mark Pincus says giving children agency, responsibility, and room for eccentricity matters more than achievement.
Stada Weighs €6 Billion Takeover of CVC-Backed Cooper Consumer Health
Stada is exploring a potential purchase of Cooper Consumer Health from its private equity owners, people familiar with the matter said, as it hunts for acquisitions on the back of record profits.
The US in Brief: Two court setbacks for Donald Trump
Our daily political update, featuring the stories that matter
There is belief talented McAtee will flourish at Forest
James McAtee battled to be seen in his debut season at the City Ground, struggling for minutes under Nottingham Forest's four managers. There is belief at the City Ground it is only a matter of time before it comes together for McAtee, despite his struggles. To much excitement from supporters, McAtee arrived on a five-year deal worth about £30m weeks after the under-21s' Euro 2025 triumph.
Exclusive: Downed US pilot reported seeing Iranian drones swarm in ‘jellyfish’ formation
A US fighter jet pilot rescued by special forces after being shot down over Iran in April described a shocking sight before ejecting from his aircraft: multiple Iranian drones hovering in the air, moving as one, in a formation that resembled a jellyfish, according to four sources familiar with the matter.
New images show what’s behind the tarp at the Kennedy Center
New images obtained by CNN show the Kennedy Center signage with President Donald Trump’s name removed, confirming a sworn court declaration from the arts center’s executive director Matt Floca that the president’s name is no longer affixed to the building.
Cubs BCB After Dark: Who leaves the rotation?
The late-night/early-morning spot for Cubs fans asks who should go to the bullpen (or Iowa) when Matthew Boyd returns.
SJP celebrates her and Matthew Broderick's daughters' 17th birthday with never-before-seen photos
'Sex and the City' star Sarah Jessica Parker celebrates the 17th birthday of her and Matthew Broderick's twin daughters, Tabitha and Loretta, with never-before-seen photos.
NASA’s Cold Atom Lab is creating one of the weirdest forms of matter in space
NASA’s upgraded Cold Atom Lab is turning the International Space Station into a frontier for quantum research, creating ultra-cold matter that behaves in astonishing ways. The experiments could unlock new discoveries about the universe while paving the way for powerful future technologies in space and on Earth.
Firings now underway at Office of Director of National Intelligence, source says
The large-scale cuts that President Donald Trump’s acting director of national intelligence had been considering imposing at his own office started on Monday, a source familiar with the matter told CNN.
New supply chain report claims the iPhone Ultra will be unveiled as scheduled
When it will actually be released is another matter. Last week, a report from Apple's supply chain indicated that the iPhone Ultra would be delayed. This...
Politics without decency has no bottom
Bill Britt argues democracy weakens when leaders abandon shame, restraint and the basic standards decency requires from public life today.
House Speaker Introduces Hospital Cost Review Board and New Health Tax
Michigan House Speaker Matt Hall (R-Richland Township) announced legislation on June 18 that would establish a hospital cost review board and create new health facility consolidation measures.
Kaiser's use of secret AI scribes sparks mental health privacy fears
Mental health professionals at Kaiser are raising concerns about an artificial intelligence tool that records medical appointments, saying it should have more safeguards.
‘Delay and deny’ insurance practices hinder health care, CT patients, doctors say
Local doctors, lawmakers, patients and the American Medical Association, say that the number of prior authorizations and claim denials that insurance companies issue is worsening.
Scientists thought they knew what's lurking at the centre of our Galaxy. But they may have been completely wrong this whole time | BBC Sky at Night Magazine
Could the supermassive black hole at the centre of the Milky Way Galaxy be dark matter instead? Exploring the science behind the theory.
Science Writer Takes Aim at Many Universes Theory
What these speculations point to is the way new findings have destroyed classical materialism. Materialism isn’t so much dying out as breaking up.
California braces for one of the biggest tax hikes in the last decade
California lawmakers and the governor this year are preparing to implement major tax hikes in a matter of weeks, representing one of the largest tax increases in the state within the last decade.
Abigail Thorn is ready to storm 'House of the Dragon' Season 3
Even among the established "House of the Dragon" stars at the glamorous June 21 Season 3 premiere in London − including Olivia Cooke, Emma D'Arcy and Matt Smith − newcomer
The Democratic Party Is Weak. This May Be a Good Thing Ahead of 2028
The Democratic Party is weaker than ever, and it's inability to force through a 2028 presidential nominee may be a good thing, writes Matt Bai.
England vs New Zealand: Matt Henry ends hosts' miserable fortnight
England's miserable fortnight ends with a crushing defeat in the second Test against New Zealand at The Oval - setting up a high-stakes decider at Trent Bridge.
New steps lead to a major renovation on the Ligonier home tour
Moving to Western Pennsylvania from Boca Raton, Fla., Matt and Ruth Redmond wanted a century-old house that needed a major rehab, and they knew exactly...
Arrakihs, a Spanish mission to illuminate the mystery of dark matter: ‘We have broken molds’
Four-telescope astronomical observatory is at the heart of the first space exploration to be led by the country
It's Official: Third Galaxy Found With No Dark Matter May Solve an Epic Mystery
We've never seen anything like this.
A $75,000 Problem in My Business Taught Me the One Leadership Skill That Matters Most
Great leaders demonstrate strong judgment by surfacing problems early, preserving options, and enabling teams to act before it’s too late.
🎧'The timing is the biggest surprise'
BBC Radio Oxford's podcast 'The Dub' give their views on Oxford United dismissing head coach Matt Bloomfield.
Why the space in ‘health care’ matters
When STAT polled our readers on ‘health care’ vs. ‘healthcare,’ about 60% of our readers voted for one word.
Matt LeBlanc, Lisa Kudrow, Tony Danza, and more remember James Burrows
Many of the TV stars who worked with James Burrows, including Matt LeBlanc, Lisa Kudrow, and Tony Danza remember the prolific director after his death at 85.
AACSB Accreditation in Graduate Business: Why It Matters
The Value of AACSB Accreditation in Graduate Business: Only 6% of schools meet standards employers recognize globally for career advancement.
Get Real With SOMD Politics: Delegate Matt Morgan Focuses On Taxes, Housing And Protecting Southern Maryland’s Rural Character
ST. MARY’S COUNTY, Md. — Republican Delegate Matt Morgan says rising taxes, government overreach and housing affordability remain among the most pressing issues facing Maryland residents as he seeks another term representing District 29A in the Maryland House of Delegates, according to a recent appearance on The BayNet’s podcast, “Get Real With Southern Maryland Politics” […]
Calmatters: California Is Getting Ready To Increase A Health Insurance Tax. Will It Affect Your Premium?
CalMatters
Dunlap wins Democratic nomination for Maine’s 2nd Congressional District
The seat is open following the surprise decision in November by U.S. Rep. Jared Golden, a Democrat, not to seek reelection.
The US in Brief: Meet America’s next socialist mayor
Our daily political update, featuring the stories that matter
Trump’s new acting intel chief Bill Pulte arrives early, eyes firing hundreds
President Donald Trump’s pick for acting director of national intelligence, Bill Pulte, showed up at his new job a day early on Thursday after asking for a list of every employee in the office so he could assess whether to fire them, two sources familiar with the matter told CNN.
Matt Dunlap Wins Democratic House Primary in Maine’s Swing District
Mr. Dunlap, a progressive Democrat, is set to face former Gov. Paul LePage, a Republican, in a competitive general election in November.
The nation’s cartoonists on the week in politics
Every week political cartoonists throughout the country and across the political spectrum apply their ink-stained skills to capture the foibles, memes, hypocrisies and other head-slapping events in the world of politics. The fruits of these labors are hundreds of cartoons that entertain and enrage readers of all political stripes. Here's an offering of the best of this week's crop, picked fresh off the Toonosphere. Edited by Matt Wuerker.
Einstein’s “biggest blunder” may finally have an explanation
Scientists have uncovered a surprising connection between quantum gravity and an exotic quantum state of matter that could explain why the universe isn’t expanding wildly fast. The study suggests that the very shape of space-time may protect the cosmological constant from disruptive quantum effects.
California is getting ready to increase a health insurance tax. Will it affect your premium?
Private plans say they'll pass the cost to consumers — meaning families could pay $400 more a year to help keep Medi-Cal afloat.
In Good Health: The Matter Of Male Fertility
When a couple struggles to conceive, the assumption is often that there is something wrong with the woman. Women are evaluated for infertility far more often than men. But male factor infertility accounts for about half of all infertility cases. And when that’s the case, men are less likely to talk about it, seek support, or even get tested in the first place. In this installment of our “In Good Health” series, we talk about male infertility — what causes it, what can be done about it, and what it’s like to go through it.Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.
Golf Trio Earns College Sports Communicators Academic All-District
CHICAGO – A trio of DePaul golfers, Rohan Gopaldas , Dominic Lucchesi and Matthew Rastogi , has earned College Sports Communicators Academic All-District hon...
Single-payer healthcare in California is possible. An economic and political thicket stands in the way
A pathway to single-payer healthcare would require dozens — or even hundreds — of difficult economic and political choices.
Single-payer healthcare in California is possible. An economic and political thicket stands in the way
A pathway to single-payer healthcare would require dozens — or even hundreds — of difficult economic and political choices.
In politics: Hoyer votes a Hoyer-free ballot, Percy convicted, Schmoke steps down
Rep. Steny Hoyer votes for a congressional candidate not named Steny Hoyer, one-time Annapolis lobbyist Davion Percy convicted in federal court, and Kurt Schmoke sets a retirement date from the University of Baltimore, in political notes.
Prediction markets are creating new opportunities for unregulated insider trading and unethical betting by turning politics into a game
Matt Motta, Boston University and Robert Ralston, University of Birmingham
Matthew McConaughey, Woody Harrelson reunite for meta show 'Brothers'
Matthew McConaughey and Woody Harrelson could be brothers from the same father, both in real life and in a new show.
Apple Prepares Second-Generation iPhone Air for Spring 2027
Apple Inc. is preparing a second-generation iPhone Air for spring 2027, aiming to boost the appeal of the slimmed-down device, according to people with knowledge of the matter.
Mikayla Matthews Shares How She Snacks to Satisfy ‘Cravings’ Amid Her ‘Long Health Journey’ With Chronic Illness (Exclusive)
Mikayla Matthews shares how chronic health issues have shaped her snacking habits, work and family life while discussing her Snackish partnership.
A deadly fungus that can infect cats and people is spreading
It’s just a matter of time before Sporothrix brasiliensis reaches the U.S. a CDC expert says.
‘Then there’s the matter of national security’
Opinion, comment and editorials of the day
Jelly Roll’s daughter speaks out on his divorce from Bunnie Xo
Jelly Roll's daughter, Bailee Ann, broke her silence on his split from Bunnie Xo, sharing she is 'disgusted by how invested' people are in the personal matter.
Amazon Hires Matt Schwimmer to Lead Creator Business Development
The exec joins after working at sports podcast company Better Collective as the chief executive of Playmaker, a sports media platform.
The US in Brief: Trump gets bruised in the Peach State
Our daily political update, featuring the stories that matter
Twins 12, Rangers 2: 17 hits secure a series win
The lineup provided more than enough run support for Zebby Matthews as the Twins blowout the Rangers.
Australia court bans former Star Entertainment CEO for six years, fines $495,000
Australia's Federal Court on Wednesday banned former Star Entertainment CEO and managing director Matthias Bekier from managing corporations for six years, and fined him A$700,000 ($494,620.00) over breaches tied to the handling of risks associated with money laundering and criminal activity.
WHO Step-by-Step programme recognized as a promising innovation for mental health in humanitarian settings
WHO, in collaboration with the Pan American Health Organization (PAHO) and Lebanon’s National Mental Health Programme, showcased Step-by-Step at the World Bank Group’s biennial Fragility Forum in Washington, DC. The forum convened more than 1500 representatives from governments, international organizations and civil society to advance the development agenda in the world’s most fragile and crisis-affected communities. WHO was invited to demonstrate Step-by-Step – a digital self-help intervention for depression, alongside innovations presented by Stanford University and Google. The World Bank Group selected Step-by-Step from among more than 50 innovations that they reviewed in the lead up to the Forum.About Step-by-StepStep-by-Step is a free digital tool developed by WHO in collaboration with Lebanon’s National Mental Health Programme and other partners, that helps people manage depression and anxiety on their own, with light guidance from a trained supporter. It uses a picture-based story to walk users through evidence-based techniques for managing common mental health conditions. Users complete five modules, with weekly contacts – of around 15 minutes each – from a trained non-specialist helper, such as a community health worker.Evidence-basedClinical trials in Lebanon involving nearly 1250 participants – including 680 Lebanese participants and 569 Syrian participants – showed that Step-by-Step significantly reduced depression, anxiety and stress, and improved daily functioning. By the end of the programme, a reduction in depressive symptoms of more than 50% was reported by almost half (46%) of Lebanese participants and more than one third (37%) of Syrian participants compared to approximately 14% of those who did not use the programme. Cost-effectiveness analyses further suggest that Step-by-Step may offer a cost-saving response to depression in humanitarian emergencies in low- and middle-income countries.Used globallyStep-by-Step is already in use nationwide in Lebanon and Thailand, as part of each country’s mental health system. In India, the NGO – Kaya Guides – has adapted Step-by-Step for delivery through a widely used messaging app. Together, these programmes have provided thousands of people with evidence-based support for depression. The content is freely available from the WHO website for any organization or country to adapt for their own context.A new implementation guideThe Fragility Forum coincided with the recent launch of WHO’s new practical guide: Psychological self-help interventions: delivering self-help for individuals, featuring Step-by-Step and Doing What Matters in Times of Stress (WHO, 2026). The guide is designed to help governments, health workers, organizations and planners bring evidence-based mental health support to more people, particularly in low-resource and crisis-affected settings.
Latvia pilots citizen engagement in research grant evaluations
Latvia has introduced an element of citizen engagement to the evaluation of nationally funded research grants. The aim is to both create more connections between science and society, and to improve the quality of its evaluations. The move comes as research funders across Europe are experimenting with ways to improve evaluation processes in the face of a sharpened focus on science’s impact on society. Evaluators of grant applications submitted to Latvia’s Fundamental and Applied Research Programme (FLPP), the country’s main research funder, will this year have the option of consulting citizen feedback on challenges the public thinks science should focus on to inform their decisions. “In recent years, both public discussions and policy-level debates in Latvia have highlighted the importance of demonstrating how publicly funded research contributes to society, the economy and the resolution of real-world challenges,” said a source at the Latvian Council of Science (LCS), which manages the FLPP. “At the same time, research institutions themselves expressed interest in improving the project evaluation framework while continuing to ensure that funding is awarded to the highest-quality projects,” the source added. The citizen input comes from a survey that was conducted between 25 February and 16 March 2025, to which 1,737 people responded. It gathered information on what the public views as problem areas for Latvia, and the role of science and technology in providing solutions to these problems. A summary of these responses has been included as an annex to the FLPP 2026 call for proposals that evaluators can refer to, purely in an advisory manner, when judging proposals. Results from the survey show that the main problem areas identified by the public were in healthcare and public health, followed by the development of new treatment methods and medicines, and then digital technology, data security and cyber security. At the bottom of the list was research aimed at acquiring new knowledge about the universe, matter and the laws of nature. Further analysis looked at the public view of the possible role of science in solving these problems. The survey charted 4,167 individual responses based on open-ended questions that were derived from the participants’ answers. The analysis again found that medical and health sciences topped the scoring, with 788 responses referring to the field. Humanities and the arts were bottom of the list, with 625. Digging further into the details, the survey suggests citizens are aware of and concerned about a number of research areas. This includes technologies and innovation to improve the environment or reduce pollution, the development of modern military technologies and cybersecurity tools, and the development and application of artificial intelligence, among others. “We hope this initiative will help strengthen public trust in science and create a more meaningful dialogue between researchers and society,” the LCS source said, adding that it offers benefits to researchers, evaluators and to the general public. More space for citizen engagement in evaluationsThere is a gradual but increasing use of citizen engagement in research evaluation processes around Europe, especially in healthcare, but it remains relatively rare, said Henry Sauermann, a professor at the European School of Management and Technology in Berlin and an expert in citizen science.“Given that we are at a point where citizen involvement is extremely limited, there is presumably space for more, but it's not that we should do it just because we want to do it,” he told Science|Business. He said some research lends itself better to having citizen input, and this usually tends to be on the applied end of the science spectrum where the public can offer useful feedback based on their experiences. He added that advising scientists on certain topics to study is also a useful approach, in the way that Latvia is doing. “The public does fund a lot of science, there's a lot of tax money going into this. We of course do want to preserve academic freedom, but it's also not unreasonable to incorporate more feedback or input from citizens where possible,” he said. Related articlesCitizen science: where, when, and how to let the public contribute to researchHow can Europe cope with a flood of AI-assisted research grant proposals?Data Corner: Horizon Europe’s AI, digital and data call success rate is 5.2%There are several ways of involving citizens in science funding. The most minimal way is having a few representatives on a panel, such as members of a patient group or union. The most direct way is crowdsourcing funding for specific projects. There is an increasing number of online platforms that allow the public to chip in to support scientific proposals.Sauermann studied this in a recent paper and found that it can have its uses, but it still is not clear if there are benefits to it. There are various assumptions linked to citizen engagement, for example that it increases public trust in science, or that it provides a representative view of what the public thinks about science. These are not necessarily true, Sauermann found. People who participate in engagement activities tend to already be very trusting of science, and, on the whole, it is generally the well-off and well educated who contribute, giving a narrow view of public opinion. On whether citizen input can help manage the increasing number of proposals that are being submitted due to assistance from AI, Sauermann is more sceptical. “The obvious answer to the flood of AI-written proposals is AI-driven evaluation,” he said, adding that it doesn’t mean citizen engagement shouldn’t be a part of evaluations in a well thought-out manner. Southern Denmark’s successful approachOne successful example of citizen engagement in science evaluations was implemented in southern Denmark. Between 2019 and 2025, citizens in the region were invited to vote to fund one of five pre-selected projects in the field of healthcare. The project, called A Healthier Southern Denmark, was a collaboration between regional authorities, the University of Southern Denmark, and two media partners. Over the seven years, there were 75,000 votes and significant public engagement online and on social media. “It was a bit of a wild project, we’d never done something like that before and we were a bit nervous about what would be said in the media about it. But actually, people were very positive,” said Anne Kathrine Overgaard, one of the main organisers of the project from the University of Southern Denmark. The university and its researchers have learned a lot from the experience, particularly about engaging with society and shaping their research to match real-world needs. This is important with Europe’s increasing focus on competitiveness and bringing innovations to market faster, Overgaard said. She hopes to see more citizen engagement in evaluation processes and in science more broadly. “For many years, citizen engagement has been a bit of an add-on to proposals, just to check a box. But I think things are changing,” she said. It’s less about citizens just gathering data and more “about the dialogue between the public and the scientists,” she said. The initiative ended last year as the team wanted to regroup to find fresh momentum. The development of AI and AI-written proposals has made Overgaard reflect on how the project could be reworked to help evaluators. She hopes to bring it back in the future. “It could be a good idea to try this initiative again in a slightly re-worked format,” she said.
Billy Bush blasts Al Roker as 'vindictive,' 'rageful' during their 'Today' run: 'He's a mean person'
Billy Bush claims 'Today' cohosts Matt Lauer and Al Roker, whom he says were 'territorial' during their time together on the morning show, 'definitely did not want me there.'
Inspired Entertainment (INSE) Uses Paddy Power Renewal to Reinforce Its Retail Betting Base
Inspired Entertainment, Inc. (NASDAQ:INSE) is one of the best e-gaming and sports betting stocks to buy now. The company strengthened its betting-shop exposure on May 6, when it extended its long-term agreement with Paddy Power to remain the exclusive provider of gaming terminals and content across Paddy Power’s UK retail estate. The agreement matters because […]